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The thymic function to produce self-protective and
self-tolerant T cells is chiefly mediated by cortical
thymic epithelial cells (cTECs) and medullary TECs
(mTECs). Recent studies including single-cell tran-
scriptomic analyses have highlighted a rich diversity
in functional mTEC subpopulations. Because of their
limited cellularity, however, the biochemical charac-
terization of TECs, including the proteomic profiling
of cTECs and mTECs, has remained unestablished.
Utilizing genetically modified mice that carry
enlarged but functional thymuses, here we show a
combination of proteomic and transcriptomic pro-
files for cTECs and mTECs, which identified signa-
ture molecules that characterize a developmental
and functional contrast between cTECs and mTECs.
Our results reveal a highly specific impact of the thy-
moproteasome on proteasome subunit composition
in cTECs and provide an integrated trans-omics plat-
form for further exploration of thymus biology.INTRODUCTION
The thymus is a pharyngeal epithelial organ that produces
T cells, which play a central role in the immune system to protect
our bodies from infectious agents and transformed malig-
nancies. The T-cell-producing function of the thymus is chiefly
mediated by thymic epithelial cells (TECs) and their subpopula-
tions (Boehm 2008; Blackburn and Manley, 2004; Rodewald,
2008). Cortical TECs (cTECs)—which structurally constitute the
thymic cortex—induce the differentiation of hematopoietic pro-
genitor cells to the T-lymphoid lineage and promote the positive
selection of functionally competent T cells, whereas medullaryThis is an open access article under the CC BY-NTECs (mTECs)—which primarily form the medullary region of
the thymus—attract positively selected T cells from the cortex
and install self-tolerance in positively selected T cells by deleting
self-reactive T cells and promoting the generation of regulatory
T cells (Anderson and Takahama, 2012; Derbinski and Kyewski,
2010; Takahama et al., 2017).
Unbiased transcriptomic analysis has powerfully advanced
our understanding of the biology of TECs. Global gene expres-
sion analysis has identified promiscuous gene expression in
mTECs (Anderson et al., 2002; Derbinski et al., 2005; Sansom
et al., 2014; Miller et al., 2018), and single-cell RNA sequencing
analysis has revealed an enormous diversity in mTEC subpopu-
lations, including the recently described thymic tuft cells (Mere-
dith et al., 2015; Bornstein et al., 2018). In addition to transcrip-
tomic analysis, proteomic analysis is an unbiased and powerful
approach to gain insight into the molecular basis for cellular
development and functions. Proteomic profiling of cTECs and
mTECs is particularly interesting because these self-antigen-
presenting cells possess distinct machinery of protein process-
ing and peptide presentation to coordinately shape the immuno-
competent and self-tolerant TCR repertoire in T cells (Anderson
and Takahama, 2012; Klein et al., 2014; Kondo et al., 2019). In
contrast to transcriptomic analysis, however, proteomic analysis
has not been established in TECs and their subpopulations. This
is in part due to the necessity of a large number of cells for mass
spectrometric proteomic analysis (i.e., typically >53 105 cells in
one run), despite the limited availability of mouse TEC cellularity
(e.g., typically <5 3 103 cTECs sorted from one mouse) and the
loss of functionally relevant molecules in the monolayer propa-
gation of TEC lines.
In the present study, we utilized a genetically modified mouse
that carries an enlarged thymus to overcome the limited avail-
ability of TECs for proteomic analysis. The keratin 5 promoter-
driven epithelial cell-specific expression of cyclin D1 causes
epidermal proliferation and severe thymic hyperplasia (Robles
et al., 1996). The cyclin D1 expression in keratin 5-expressingCell Reports 29, 2901–2916, November 26, 2019 2901
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. K5D1 Thymus Produces Functionally Competent and Self-Tolerant T Cells
(A) Flow cytometric analysis of TECs from B6 and K5D1 mice. Plots on the left show the number (means and SEMs, n = 5) of CD45EpCAM+PI viable TECs. Dot
plots on the right show UEA1 and Ly51 expression profiles of CD45EpCAM+PI viable TECs.
(B) Flow cytometric analysis of thymocytes from B6 and K5D1 mice. Plots on the left show the number (means and SEMs, n = 5) of total thymocytes. Dot plots on
the right show CD4 and CD8 expression (left) and TCRb and TCRd expression (right) in PI viable thymocytes.
(C) Immunofluorescence analysis of thymic sections from K5D1 mice. Top: b5t (green), UEA1 reactivity (blue), and Aire (magenta). Bottom: CD4 (green), CD8
(blue), and UEA1 reactivity (red). Representative data from three independent experiments are shown. Scale bars, 100 mm.
(D) Flow cytometric analysis of thymocytes from K5D1-b5t+/ heterozygous (Het) and K5D1-b5t/ knockout (KO) mice. Plots show cell number (means and
SEMs, n = 3) of CD4+CD8TCRbhigh and CD4CD8+TCRbhigh thymocytes.
(E) Flow cytometric analysis of spleen cells from B6 and K5D1 mice. Dot plots on the left show CD4 and CD8 expression in TCRbhigh PI viable cells. Plots on the
right show cell number (means and SEMs, n = 5) of CD4+CD8TCRbhigh and CD4CD8+ TCRbhigh cells.
(legend continued on next page)
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TECprogenitors causes amassive enlargement of the thymus by
increasing the cellularity of TECs (Klug et al., 2000). Importantly,
the enlarged thymus maintains the corticomedullary structure
and the capability to produce T cells (Robles et al., 1996; Klug
et al., 2000; Bolner, 2015). We show that cTECs and mTECs in
the enlarged thymuses of these mice are massively expanded
in cellularity yet are functionally potent in supporting the devel-
opment and selection of immunocompetent and self-tolerant
T cells. RNA sequencing analysis verifies the developmental fi-
delity and functional potency of cTECs and mTECs isolated
from keratin 5 promoter-driven cyclin D1-transgenic mice. By
performing mass-spectrometry-based quantitative proteomic
analysis of cTECs and mTECs in these mice, and in combination
with RNA sequencing analysis of these cells, our integrated
multi-layer omics data identify signature molecules that charac-
terize a developmental and functional contrast between cTECs
and mTECs.
By using the multi-layer omics (i.e., trans-omics) approach for
the analysis of isolated TEC subpopulations, we further exam-
ined the proteomic as well as transcriptomic profiles of cTECs
from b5t-deficient mice. b5t is a cTEC-specific component of
the thymoproteasome, which is essential for the optimal produc-
tion of immunocompetent CD8+ T cells (Murata et al., 2007; Nitta
et al., 2010; Xing et al., 2013; Takada et al., 2015). It is speculated
that MHC class-I-associated self-peptides produced in a cTEC-
specific manner by b5t-containing thymoproteasome govern the
positive selection of CD8+ T cells in the thymic cortex (Murata
et al., 2007, 2018; Sasaki et al., 2015). However, it is still unclear
how b5t contributes to the optimization of CD8+ T-cell develop-
ment. Specifically, it is uncertain whether b5t alters the proteome
and/or the transcriptome of cTECs to pervasively affect cellular
functions of cTECs, in addition to providing the proteasomal
uniqueness in the production of MHC class-I-associated unique
self-peptides. Our trans-omics analysis reveals a highly specific
impact of b5t on proteasomal subunit composition in cTECs,
rather than a pervasive effect on cTEC functions, supporting
the possibility that a b5t-containing thymoproteasome governs
CD8+ T-cell development through the proteasomal production
of MHC class-I-associated unique self-peptides in cTECs.
RESULTS
Hyperplastic Thymuses in Keratin 5 Promoter-Driven
Cyclin D1-Transgenic Mice Are Capable of Producing
andSelecting Functionally Competent and Self-Tolerant
T Cells
It was reported that the thymuses in keratin 5 promoter-driven
cyclin D1-transgenic (K5D1) mice were severely hyperplastic
while maintaining the corticomedullary structure and the T-cell-
producing capability (Robles et al., 1996; Klug et al., 2000; Bol-
ner, 2015). We found that the enlarged thymuses in K5D1 mice(F) Allogenic response of spleen T cells from B6 and K5D1 mice. Cell Trace Viole
plots on the left show CTV fluorescence and CD25 expression in TCRbhigh viable
show the frequency (means and SEMs, n = 6) of CTVlow CD25high cells in TCRbh
indicate frequency of cells within indicated area.
(G) Hematoxylin- and eosin-stained sections of eyes and salivary glands from indi
matched manner. *p < 0.05; **p < 0.01; ***p < 0.001; n.s., not significant.contained approximately 80- to 100-fold larger numbers of
TECs compared with the thymuses in age-matched control B6
mice (Figure 1A). The flow cytometric profiles of Ly51+ UEA1
cTECs and Ly51 UEA1+ mTECs in K5D1 thymuses were similar
to those in B6 thymuses (Figures 1A and S1A). Accordingly,
thymocyte cellularity in K5D1 mice increased to approximately
30- to 50-fold of that in B6 mice, without apparent alterations
in CD4/CD8 and TCRb/TCRd profiles (Figure 1B). Similar to B6
thymuses, the cortical regions in the enlarged K5D1 thymuses
were enriched with b5t+ cTECs and CD4/CD8 double-positive
thymocytes, and the K5D1 thymic medullas contained Aire+
mTECs as well as CD4/CD8 single-positive thymocytes (Fig-
ure 1C). The b5t+ cTECs in K5D1 mice were functionally potent
to optimize CD8+ T-cell production because CD4CD8+
TCRbhigh thymocytes were significantly reduced in cellularity in
b5t/ K5D1 mice, in comparison with b5t+/ K5D1 mice (Fig-
ure 1D). The thymic hyperplasia in K5D1 mice coincided with
an approximately 2- to 3-fold increase in the cellularity of
T cells in the spleen (Figure 1E). Those spleen T cells were func-
tionally competent to proliferate in response to allogeneic stimu-
lator cells, but they were self-tolerant because they were unre-
sponsive to syngeneic stimulator cells (Figure 1F). The
deficiency in Aire, which controls a variety of mTEC functions
including the ectopic expression of organ-specific self-antigens
(Mathis and Benoist, 2009), in K5D1 mice resulted in the inflam-
mation in various tissues, including the retinas and the salivary
glands (Figure 1G), indicating that Aire+ mTECs play a role in
the establishment of self-tolerance in T cells in K5D1 mice.
These results indicate that the hyperplastic thymic microenvi-
ronments, including the massively increased cellularities of
cTECs andmTECs, in K5D1mice are functionally capable of pro-
ducing and selecting immunocompetent and self-tolerant
T cells. These results also suggest that the thymuses in K5D1
mice could be a useful source of cTECs andmTECs for biochem-
ical analysis, including proteomic analysis that requires relatively
large-scale cell preparation.
Isolation of cTECs and mTECs from K5D1 Mice
We then isolated cTECs and mTECs from an enlarged K5D1
thymus for transcriptomic and proteomic analyses. According
to the most widely used method for TEC purification (Gray
et al., 2006; Sansom et al., 2014; Meredith et al., 2015; Miller
et al., 2018; Bornstein et al., 2018; Anderson et al., 1993; Sakata
et al., 2018), the K5D1 thymus and control B6 thymus were enzy-
matically digested, and cTECs and mTECs were purified simul-
taneously using magnetic enrichment followed by flow cytomet-
ric cell sorting. In comparison with the previous results (Sakata
et al., 2018), cTECs and mTECs distributed similarly (Figures
S1B–S1D) and were isolated in an equivalent efficiency (Fig-
ure S1E) between K5D1 and B6 thymuses. Microscopic inspec-
tion of the highly purified cTECs and mTECs (Figures 2A and S2)t (CTV)-labeled splenocytes were cultured with stimulator cells for 6 days. Dot
cells from K5D1 mice cultured with indicated stimulator cells. Plots on the right
igh viable cells from B6 mice (left) and K5D1 mice (right). Numbers in dot plots
cated mice. Bars, 100 mm. Mice were analyzed at 10 to 20 weeks old in an age-
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Figure 2. Isolated cTECs but not mTECs
Contain Thymic Nurse Cells
(A) Flow cytometric analysis of enzyme-digested total
thymic cells (top), CD45EpCAM+UEA1Ly51+ iso-
lated cTECs (middle), and CD45EpCAM+
UEA1+Ly51 isolated mTECs (bottom) from B6 and
K5D1 mice. Shown are profiles of EpCAM and
CD45+PI expression in total cells (left) and UEA1
reactivity and Ly51 expression in PICD45EpCAM+
viable cells (right). Numbers in dot plots indicate
frequency of cells within indicated area.
(B) Confocal microscopic analysis of isolated cTECs
and mTECs. Cells were fixed, permeabilized, and
stained for CD45. Shown on the left are representa-
tive images of CD45+ thymocytes (green) in Ly51+
cTECs (top) and UEA1+ mTECs (bottom) isolated
from B6 mice (left) and K5D1 mice (right). Left plots
show the frequency of thymocyte-containing cTECs
(top) and mTECs (bottom) in total cTECs andmTECs,
respectively. Numbers show average frequencies.
Right plots show the number of thymocytes in
thymocyte-containing cTEC (top) and mTEC
(bottom). Numbers show average thymocyte
numbers. Means and SEMs from 10 to 20 images in
two independent experiments are shown.
(C) Fluorometric measurement of RNA amount
(means and SEMs, n = 3) per 53 103 flow-cytometry-
isolated CD4+CD8+ (DP) thymocytes, cTECs, and
mTECs from K5D1 mice. Numbers (pg) show
deduced average RNA amount per cell.
(D) Fluorometric measurement of protein amount
(means and SEMs, n = 3) per 1 3 105 flow-cy-
tometry-isolated CD4+CD8+ (DP) thymocytes,
cTECs, and mTECs from K5D1 mice. Numbers
(pg) show deduced average protein amount per
cell.revealed that 15% and 22% of cTECs isolated from the B6 and
K5D1 thymuses, respectively, were multicellular complexes, in
which the cTECs enclosed four to eight CD4+CD8+ thymocytes
(Figure 2B). These multicellular cTEC-thymocyte complexes,
previously described as thymic nurse cells (TNCs), resulted
from persistent interactions between a fraction of cTECs and
long-lived CD4+CD8+ thymocytes (Wekerle and Ketelsen,
1980; Kyewski and Kaplan, 1982; Nakagawa et al., 2012). The
CD4+CD8+ thymocytes in the TNC complexes were completely
enclosed within large cTECs (Wekerle and Ketelsen, 1980;
Kyewski and Kaplan, 1982; Nakagawa et al., 2012) and therefore2904 Cell Reports 29, 2901–2916, November 26, 2019were inevitably co-purified with cTECs that
were purified on the basis of cell-surface
molecules. Unlike cTECs, however,
mTECs did not form multicellular com-
plexes with thymocytes (Figure 2B).
Consequently, we estimated the contri-
bution of TNC-enclosed CD4+CD8+
thymocytes in RNA and protein samples
prepared from cTECs. Fluorometric mea-
surements indicated that 21.3 ± 2.5 ng
(n = 3) and 5.1 ± 0.4 ng (n = 3) of RNAs
could be extracted from 5 3 103 flow-cy-
tometry-purified cTECs and CD4+CD8+thymocytes, respectively (Figure 2C), which deduced 4.3 ± 0.5
pg and 1.0 ± 0.1 pg of RNAs from one cTEC and one
CD4+CD8+ thymocyte, respectively (Figure 2C). Because the
isolated cTECs from either K5D1 or B6 mice included 15% to
22% of TNC complexes containing four to eight CD4+CD8+ thy-
mocytes (Figure 2B), we estimated from simple calculation (RNA
amount per one CD4+CD8+ thymocyte 3 the number of
CD4+CD8+ thymocytes per one TNC 3 the frequency of TNCs
per total cTECs / RNA amount measured in one cTEC) that
73% to 80% of RNAs extracted from the isolated cTECs were
indeed derived from cTECs, and the rest (20% to 27%) of those
RNAs were actually derived from TNC-enclosed CD4+CD8+ thy-
mocytes (Figure 2C). From similar fluorometric measurements of
the amounts of proteins extracted from isolated cTECs and
CD4+CD8+ thymocytes, we deduced that 95% to 97% of pro-
teins extracted from the isolated cTECs were derived from
cTECs, and the rest (3% to 5%) of those proteins from the iso-
lated cTECs were derived from TNC-enclosed CD4+CD8+ thy-
mocytes (Figure 2D). The difference in the contribution of
CD4+CD8+ thymocytes to RNA compared to protein correlated
with the difference in fold change in protein amount and RNA
amount between large cTECs and small CD4+CD8+ thymocytes
(Figure 2D).
These results demonstrate that we can isolate cTECs and
mTECs at a high purity from K5D1 mice. However, current tech-
nologies for TEC purification inevitably include TNC complexes
in the isolated cTECs. In both K5D1 and B6 cTECs, it was esti-
mated that 20% to 27% of RNA and 3% to 5% of proteins ex-
tracted from the isolated cTECs were actually derived from
TNC-enclosed CD4+CD8+ thymocytes. On the contrary, mTECs
did not form those multicellular complexes with thymocytes and
therefore could be isolated free from thymocytes.
RNA Sequencing Analysis of cTECs and mTECs Isolated
from K5D1 Mice
By using the replicates (n = 3) of these highly purified cells (Fig-
ure S2), we next examined the transcriptomic profiles of isolated
cTECs and mTECs from an enlarged K5D1 thymus by RNA
sequencing analysis. All experimental replicates were
sequenced at approximately 2 3 107 reads for 1.5 to 2 3 104
genes per sample (Figure S3A). The number of genes detected
was larger in mTECs than in cTECs (Figure S3B), in agreement
with previously reported results (Sansom et al., 2014) and likely
reflecting promiscuous gene expression in mTECs (Anderson
et al., 2002; Derbinski et al., 2005; Sansom et al., 2014). Unsu-
pervised hierarchical cluster analysis validated the experimental
replicates, all of which were closely clustered with each other
(Figure 3A). We found that the global profiles of gene expression
were highly distinct between cTECs and mTECs (Figure 3A), in
agreement with previous reports (Sansom et al., 2014; Heng
et al., 2008; Immunological Genome Project, http://www.
immgen.org). Importantly, those profiles were very similar be-
tween K5D1 and B6 cells (Figure 3A). Principal component anal-
ysis confirmed differences in gene expression profiles between
cTECs and mTECs and the similarities between K5D1 and B6
cells (Figure 3B). The correlation plot of the fold changes be-
tween mTEC signals and cTEC signals further pointed to the
sharp contrast between cTECs and mTECs and the strong sim-
ilarity between K5D1 and B6 cells in the gene expression profiles
(Figure 3C). Comparable distribution in the mTEC/cTEC fold
changes among individual samples further highlighted the simi-
larity in global gene expression between K5D1 and B6 cells
(Figure S3C).
The minor difference in mTEC genes between K5D1 and B6
mice, which was detected in the secondary principal compo-
nents (Figure 3B), was primarily due to the overexpressed
Ccnd1, encoding cyclin D1, and other cell-cycle-associated
genes, including Ccnb1 (encoding cyclin B1), Ccna2 (cyclin
A2), and Fbxo5 (F-box protein 5), more strongly expressed inK5D1 mTECs than in B6 mTECs (Figure 3D). Gene Ontology
enrichment analysis confirmed that differentially expressed
genes between B6 mTECs and K5D1 mTECs were involved in
the cell cycle, mitotic nuclear division, and cell division (Fig-
ure 3D). Ccnd1 was also overexpressed in cTECs in K5D1
mice, but the overexpression of the other cell-cycle-associated
genes was not clearly highlighted in K5D1 cTECs (Figure 3E),
possibly because the keratin 5 promoter-driven gene expression
is less pronounced in cTECs than in mTECs and cTEC/mTEC-bi-
potent TEC progenitors (Klug et al., 1998) and because cTECs
are less proliferative than mTECs (Gray et al., 2006). Instead,
the Gene Ontology enrichment analysis revealed that the minor
difference in cTEC genes between K5D1 andB6mice (Figure 3B)
predominantly resulted from the difference in the expression of
adaptive immune-cell-associated genes, including Rag2
(RAG2), Zap70 (ZAP70), and Cd8a (CD8a), which were detected
more in B6 cTECs than in K5D1 cTECs (Figure 3E); this coincides
with the slightly higher frequency of CD4+CD8+ thymocytes en-
closed in isolated B6 TNCs (eight thymocytes in 15% cTECs)
than in isolated K5D1 cTECs (four thymocytes in 22% cTECs)
(Figure 2B).
The expression profiles of genes that were associated with the
unique functions of cTECs (e.g., Ctsl [cathepsin L], Dll4 [DLL4],
Psmb11 [b5t], and Prss16 [TSSP]) and mTECs (e.g., Xcl1
[XCL1], Ccl21a [CCL21Ser], Tnfrsf11a [RANK], Tnfrsf11b
[OPG], and Aire [AIRE]) were markedly different between cTECs
and mTECs but were indistinguishable between the cells pre-
pared from K5D1 mice and those from B6 mice (Figure 3F).
The genes that were highly detected in mTECs over cTECs
included Aire-dependent and Aire-independent promiscuously
expressed genes, encoding tissue-restricted self-antigens
(Figure 3G).
These results indicate that the global profiles of gene expres-
sion in cTECs and mTECs isolated from K5D1 mice are very
similar to those from B6 mice, except for the overexpressed cy-
clin D1 and the consequent expression of cell-cycle-associated
genes. Our results also reconfirm the previously described sharp
contrast in gene expression profiles between cTECs and
mTECs. The genes detected in isolated cTECs inevitably include
TNC-enclosed CD4+CD8+ thymocyte-derived genes, which
were also detected in isolated cTECs in previous reports
(Sansom et al., 2014; Immunological Genome Project, http://
www.immgen.org).
Proteomic and Trans-omics Analyses of cTECs and
mTECs
Because the use of K5D1 mice allowed us to readily collect >105
cTECs and >105 mTECs per mouse (Figure 1), and because the
functional and transcriptomic profiles of cTECs and mTECs iso-
lated from K5D1 mice were highly similar to those from B6 mice
(Figures 1 and 3), we next performed mass-spectrometry-based
quantitative proteomic analysis of cTECs and mTECs isolated
from K5D1 mice. Proteins extracted from isolated cTECs and
mTECs were digested with trypsin, and the peptides were
labeled with tandem mass tags (TMTs). A high-confidence anal-
ysis at 1% false discovery rate (FDR) of liquid chromatography-
tandem mass spectrometric (LC-MS/MS) profiles identified and
quantified 5,753 protein species from cTECs and mTECsCell Reports 29, 2901–2916, November 26, 2019 2905
Figure 3. RNA Sequencing Analysis of cTECs and mTECs
(A) Unsupervised hierarchical cluster analysis and heatmap for detected genes in cTECs and mTECs (n = 3) isolated from B6 mice and K5D1 mice.
(B) Principal component (PC) analysis of RNA sequencing data of indicated cell populations.
(C) Correlation plot analysis of the transcriptome according to log2 fold change (mTECs/cTECs) between B6 and K5D1 TECs.
(D and E) Enrichment analysis of the ontology for genes that are differently expressed (RPKM > 1, log2 fold change > 1 or < 1, Q < 0.05) between B6 and K5D1
TECs. Bars show the adjusted p values of top 5 categories enriched in mTECs (D) and cTECs (E). Numbers in parentheses indicate the number of categorized
genes.
(F) Unsupervised hierarchical cluster analysis and heatmap of genes that are associated with the unique functions of cTECs and mTECs.
(G) Unsupervised hierarchical cluster analysis and heatmap of Aire-dependent (top) and Aire-independent (bottom) promiscuously expressed genes. pGE,
promiscuous gene expression.isolated from K5D1 mice (Table S1). We found a sharp contrast
between cTECs andmTECs in their proteomic profiles, including
the cTEC-specific detection of cathepsin L, b5t, and TSSP pro-
teins, which characterize functions unique to cTECs, and the
mTEC-specific detection of cathepsin S, AIRE, and CD40 pro-
teins, which characterize mTEC functions (Figure 4A).2906 Cell Reports 29, 2901–2916, November 26, 2019In agreement with our findings that 3% to 5% of proteins ex-
tracted from isolated cTECs were derived from TNC-enclosed
CD4+CD8+ thymocytes, whereas 20% to 27% of RNAs ex-
tracted from isolated cTECs originated from TNC-enclosed
CD4+CD8+ thymocytes (Figure 2), the proteomic profiles of
cTECs were not as much affected by the co-isolated
Figure 4. Proteomic and Trans-omics Analyses of cTECs and
mTECs
(A) Volcano plot analysis of TMT-based quantitative proteomes for cTECs and
mTECs. Detected proteins are plotted as log2 fold changes (K5D1 cTECs/
K5D1 mTECs) versus log10 Q values. Black horizontal line in the plot shows
the Q value of 0.05.
(B and C) Correlation plot analysis of trans-omics profiles for cTECs and
mTECs. Log2 fold changes of proteins differently (Q < 0.05) expressed be-
tween K5D1 cTECs and K5D1 mTECs are plotted against transcriptomic log2
fold changes between K5D1 cTECs and K5D1 mTECs (B) and B6 cTECs andCD4+CD8+ thymocyte-derived proteins as were the transcrip-
tomic profiles of cTECs (Figure S4A).
The top five proteins most abundantly detected in all TECs
were kynureninase, cathepsin H, glutathione S-transferase a2,
loricrin, and hornerin, all of which were relatively more abundant
in mTECs than in cTECs (Table S1). The top five proteins most
highly abundant in cTECs were b5t, indolethylamine N-methyl-
transferase, parvin b, NAD(P)H quinone dehydrogenase 1, and
CD83 (Table S1).
Among the 27 promiscuously expressed tissue-restricted self-
antigen genes detected in mTECs (Figure 3G), only two protein
products were detected in mTECs in the proteomic analysis:
Aire-dependent Hbb-y and Aire-independent Fabp9 (Table S1).
The rest of these genes did not produce a detectable amount
of proteins (Table S1).
This quantitative proteomic analysis identified 308 proteins
that were significantly (Q < 0.05) more abundant in mTECs
than in cTECs, and the combined multi-layer analysis with tran-
scriptomic data revealed that 202 of those 308 molecules also
showed significantly (Q < 0.05) higher mRNA expression in
mTECs than in cTECs (Figure 4B). These molecules included nu-
clear proteins important for mTEC development, such as AIRE,
relB, and NFkB2, as well as the recently described thymic tuft
cell-associated proteins, such as DCLK1, Avil, and Trpm5
(Table S2). The rest of the molecules (308 – 202 = 106 proteins)
that had significantly (Q < 0.05) higher protein expression, but
not mRNA expression, in mTECs compared to cTECs included
proteins with previously unknown roles in mTECs, although no
clear enrichment was detected in the ontology for any biological
process or cellular localization (Table S3).
On the contrary, among 232 molecules that were significantly
(Q < 0.05) more abundant in cTECs than in mTECs, 199 proteins
showed a significantly higher abundance in mRNA transcripts in
cTECs than in mTECs (Figure 4B), which included proteolytic
proteins important for cTEC functions, such as b5t, TSSP, and
cathepsin L (Table S2). The rest of the molecules (232 – 199 =
33 proteins) that had significantly (Q < 0.05) higher protein
expression, but not mRNA expression, in cTECs than in mTECs
contained proteins with previously unknown roles in cTECs,
without the enrichment of molecules in certain biological pro-
cesses or cellular localization (Table S3).
In parallel, the combined multi-layer analysis of proteomic
data from K5D1 TECs and transcriptomic data from B6 TECs
revealed that 207 of the 308 molecules that had significantly
(Q < 0.05) higher protein expression in mTECs than in cTECs in
K5D1mice showed significantly (Q < 0.05) higher mRNA expres-
sion in mTECs than cTECs in B6 mice, whereas 187 of the 232
molecules that had significantly (Q < 0.05) higher protein expres-
sion in cTECs than in mTECs in K5D1 mice showed significantly
(Q < 0.05) higher mRNA expression in cTECs than in mTECs inB6 mTECs (C). Among the 308 molecules that are significantly (Q < 0.05) more
abundant in mTECs than in cTECs in proteomic analysis, 202 (B) and 207 (C)
molecules (red symbols) are more highly detected in mTECs than in cTECs in
transcriptomic data. Among the 232 molecules that are significantly (Q < 0.05)
more abundant in cTECs than mTECs in proteomic analysis, 199 (B) and 187
(C) molecules (blue symbols) aremore highly detected in cTECs than inmTECs
in transcriptomic data.
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B6 mice (Figure 4C). More than 90% (90.5% for cTECs and
92.3% for mTECs) of the molecules overlapped between the
trans-omics plots using K5D1 transcriptomic profiles and the
plots using B6 transcriptomic profiles (Figures 4B and 4C), re-
confirming the relevance of proteomic and trans-omic profiles
obtained from K5D1 TECs.
We also analyzed the molecules that were differentially de-
tected in mRNAs but not proteins between cTECs and mTECs.
We noticed that 2,989 molecules, which were significantly
(Q < 0.05) more abundant in mTECs than cTECs in RNA
sequencing analysis but were not detected in proteomic anal-
ysis, were highly enriched with the molecules with extracellular
localization, including cytokines and chemokines such as
CCL21Ser, XCL1, and IL25 (Figure S4B; Table S4). This likely re-
flects the removal of those secretory proteins from mTECs dur-
ing single-cell preparation digested out of the thymus for prote-
omic and transcriptomic analyses. We also detected 1,070 kinds
ofmRNA transcripts that were significantly (Q < 0.05)more abun-
dant in cTECs than inmTECs in RNA sequencing analysis but not
in proteomic analysis (Table S4). The molecules that were de-
tected abundantly only in either cTECs or mTECs in mRNAs,
but not proteins, contained molecules with previously unknown
roles in TECs, without showing highly biased enrichment in the
ontology (Figure S4B; Table S4).
Thus, the combined proteomic and transcriptomic analyses
(i.e., trans-omics analysis) identified a total of 401 molecules
(202molecules abundant inmTECs and 199molecules in cTECs)
whose mRNA and protein expression levels are significantly
different between cTECs and mTECs. The results also identified
many functionally unknown molecules that were detected in
either cTEC or mTECs and were with discordant mRNA and pro-
tein abundance. The list of these molecules offers a useful
resource for further exploring the biology of cTECs and mTECs.
RNA Sequencing Analysis of cTECs Isolated from b5t-
Deficient K5D1 Mice
We then examined the transcriptomic and proteomic profiles of
cTECs isolated from b5t-deficient K5D1mice. The global profiles
of gene expression in RNA sequencing analysis were highly
similar between b5t/ and b5t+/+ cTECs isolated from either
K5D1 or B6 cells (Figure S5A). The principal component analysis
(Figure 5A) and the fold-change correlation analysis (Figure 5B)
confirmed the high similarity between b5t/ and b5t+/+ cTECs
isolated from either K5D1 or B6 cells. The minor difference be-
tween b5t/ and b5t+/+ cTECs detected in the principal compo-
nent analysis (Figure 5A) was primarily due to the difference in
the expression of Psmb11, encoding b5t (Figure 5B). The differ-
ence in Psmb11 expression was robust in the RPKM (reads per
kilobase of transcript, per million mapped reads) values of the
RNA sequencing analysis and clearly confirmed by qRT-PCR
analysis (Figure 5C). Unlike Psmb11, all other genes that were
found to be prominently different in the RNA sequencing analysis
between b5t/ and b5t+/+ cTECs from either K5D1 or B6 mice
were very low in the RPKM abundance, and the qRT-PCR anal-
ysis failed to reproduce the expression difference in most of
those less abundant genes (Figure 5C). However, we noticed
that the qRT-PCR analysis reproduced the differential expres-
sion in the functionally unknown gene Gm2004 at a significantly2908 Cell Reports 29, 2901–2916, November 26, 2019(p < 0.05) higher amount in b5t/ cTECs than in b5t+/+ cTECs
(Figure 5C).
A recent study of RNA sequencing analysis reported that
cTECs in b5t/mice had slightly (25% to 50%) reduced expres-
sion of cTEC genes, such as Enpep, Ly75, Ctsl, Prss16, Cxcl12,
Ccl25, and Dll4, and interpreted that these reductions could
reflect the acquisition of mTEC-like features by b5t/ cTECs
(Apavaloaei et al., 2019). However, none of the reported reduc-
tions in cTEC gene expression were reproduced in our data
from RNA sequencing analysis or qRT-PCR measurement (Fig-
ures 5D and S5B). Some of the cTEC-associated transcripts,
including Ctsl and Ccl25, were even slightly elevated in b5t/
cTECs in qRT-PCR analysis (Figures 5D and S5B). In addition,
unlike their description (Apavaloaei et al., 2019), b5t/ cTECs
showed neither the elevated expression of cell-adhesion-related
genes—including Itgam, Fndc1, Col3a1, Cdh13, and Cldn4 (Fig-
ures 5D and S5B)—nor the increased abundance in b-catenin
proteins (Figure 5E). Furthermore, despite their description (Apa-
valoaei et al., 2019), our analysis of thymocytes from B6 b5t/
mice showed neither an increase in the number of MHC class
Ihigh CD69low TCRbhigh CCR7high CD4+CD8- thymocytes (i.e.,
M2 CD4SP mature thymocytes) (Figures 5F and S5C) nor an in-
crease in the expression of oxidative stress genes, including
Hspa1a, Hspa1b, Fos, Jun, Gadd45a, Rhob, and Nr4a2, in
TCRbhigh CD4+CD8 mature thymocytes (Figure S5D).
These results indicate that the gene expression profiles of
cTECs are highly similar between b5t-deficient mice and control
mice in B6 background. The pervasive effects reported in cTECs
and CD4+CD8 thymocytes in b5t-deficient mice (Apavaloaei
et al., 2019) are not reproduced in our b5t-deficient mice with
B6 background and therefore cannot be generalized as a conse-
quence of b5t deficiency. Their results could have been derived
from the use ofmicewith amixed genetic background, the use of
cTECs without clarifying the purity, and/or the focus on the small
difference detected by RNA sequencing analysis without confir-
mation by quantitative mRNA measurement (Apavaloaei et al.,
2019).
To further evaluate the impact of loss of cell-type-specific b5
subunits onto TECs, we also performed the RNA sequencing
analysis of mTECs and cTECs from b5i-deficient mice. The re-
sults showed similarities in gene expression profiles between
TECs from B6-b5i-deficient mice and those from control B6
mice, indicating that the loss of b5i does not pervasively affect
basic gene expression profiles in either mTECs or cTECs
(Figure S6).
Alteration in Proteasome Components in cTECs in b5t-
Deficient Mice
By the TMT-based quantitative proteomic analysis, we further
examined cTECs isolated from b5t-deficient K5D1 mice and
control K5D1 mice. We noticed that the proteomic profiles of
cTECs were highly similar between b5t-deficient mice and con-
trol K5D1 mice (Figure 6A), in contrast to the marked difference
detected in a parallel analysis between cTECs and mTECs (Fig-
ure 4A). Even though the analysis at the same stringency (Q <
0.05) as the analysis of cTECs and mTECs (Figure 4A) pointed
to no significantly different molecules between b5t-deficient
and control cTECs (Figure 6A), a relatively modest (Q < 0.4) but
Figure 5. RNA Sequencing Analysis of
cTECs Isolated from b5t-Deficient Mice
(A) Principal component (PC) analysis of RNA
sequencing data of indicated cell populations.
b5tKO, b5t-knockout.
(B) Correlation plot analysis of transcriptome ac-
cording to log2 fold change (b5tKO cTECs/control
cTECs) between B6 and K5D1 TECs. Red lines
indicate 5 and 5 of log2 fold change.
(C) qPCR analysis of mRNA expression levels
(means and SEMs, n = 3) of indicated genes
relative to Gapdh levels in cTECs isolated from B6
and B6-b5tKOmice. Numbers at the bottom of the
plots show average RPKM values and log2 fold
change values (B6 cTECs/B6-b5tKO cTECs) of
RNA sequencing data.
(D) qPCR analysis of mRNA expression levels
(means and SEMs, n = 5 to 7) of indicated genes
relative to Gapdh levels in B6 and B6-b5tKO
cTECs. Numbers at the bottom of the plots show
average RPKM values of RNA sequencing data.
(E) Flow cytometric analysis of b-catenin expres-
sion in cTECs. Histograms show b-catenin
expression in B6-b5tHet cTECs (blue line) and B6-
b5tKO cTECs (red line). Shaded area and black
line represent the fluorescence in the absence of
anti-b-catenin antibody in B6-b5tHet cTECs and
B6-b5tKO cTECs, respectively. Plots on the right
show relative fluorescence intensity index (means
and SEMs, n = 3) of the fluorescence histograms.
(F) Flow cytometric analysis of semi-mature and
mature thymocytes from B6-b5tHet and B6-b5tKO
mice. Plots show cell numbers (means and SEMs,
n = 4) ofMHCclass IlowCD69high TCRbhighCCR7high
(semi-mature, SM), MHC class Ihigh CD69high
TCRbhigh CCR7high (mature 1, M1), and MHC class
Ihigh CD69low TCRbhigh CCR7high (mature 2, M2)
subpopulations within CD4+CD8 thymocytes (left;
4SM, 4M1, and 4M2) and CD4CD8+ thymocytes
(right; 8SM, 8M1, and 8M2).
*p < 0.05; ***p < 0.001; n.s., not significant; n.d., not
detected.clear reduction in the abundance of b5t protein was detected in
b5t-deficient cTECs (Figure 6A), in which b5t protein was
completely absent (Murata et al., 2007; Ripen et al., 2011). The
modest difference in the amount of b5t protein was most likely
due to the well-known underestimation of the quantitative differ-
ence in the TMT-labeling strategy for proteomic analysis (Ting
et al., 2011, described in detail in the STAR Methods). Nonethe-
less, our results revealed that among the quantified 5,753 pro-
teins, b5t was the protein that had by far the largest difference
in amount between b5t/ and b5t+/+ cTECs (Figure 6A).
The ontology analysis for TMT-identified proteins that were
differently (Q < 0.4) quantified between b5t-deficient and control
cTECs revealed a highly specific alteration in proteasome com-
ponents in b5t-deficient cTECs (Figure 6B). Among the 20S core
particle components of the proteasomes, all seven a-ring com-
ponents (a1–a7), all four non-catalytic b-ring components
(b3, b4, b6, and b7), and all three thymoproteasome catalyticcomponents (b1i, b2i, and b5t) were reduced in b5t-deficient
cTECs (Figure 6C). In contrast, b5t-deficient cTECs showed a
modest elevation of b5i and b5 expression (Figure 6C), which
likely reflected the compensation for the loss of b5t to form the
proteasome complexes, as previously reported (Murata et al.,
2007, 2018; Nitta et al., 2010). All ATPase components (Rpt1–
6) and non-ATPase components (Rpn1–13) of 19S regulatory
particle components were also reduced in b5t-deficient cTECs
(Figure 6D). It was also noted that unlike all other components
of core and regulatory proteasomal particles, b2 showed no sig-
nificant (Q > 0.9) differences in amount between b5t/ and
b5t+/+ cTECs (Figure 6C).
Label-free quantitative proteomic analysis (Figure 6E;
Table S5) verified that in addition to the loss of b5t proteins,
the majority of proteasome components were reduced in
b5t-deficient cTECs. LC-MS/MS-based label-free quantifica-
tion utilized the missing value imputation, which enabled theCell Reports 29, 2901–2916, November 26, 2019 2909
Figure 6. Alteration in Proteasome Components in cTECs in b5t-Deficient Mice
(A) Volcano plot analysis of proteomes for K5D1-b5tKO cTECs and K5D1 cTECs. Detected proteins are plotted as log2 fold changes (K5D1-b5tKO cTECs/K5D1
cTECs) versus log10 Q values. Black horizontal line in the plot shows the Q value of 0.05.
(B) Enrichment analysis of the ontology for proteins differently (Q < 0.4) expressed between K5D1 cTECs and K5D1-b5tKO cTECs. Bars show the adjusted
p values of top 5 categories. Numbers in parentheses indicate the number of categorized proteins.
(C and D) Volcano plots for 20S proteasome components (C) and regulatory particle proteasome components (D). Plotted are log2 fold changes (K5D1-b5tKO
cTECs/K5D1 cTECs) versus log10 Q values for individual components.
(E) Label-free proteomic analysis of protein abundance of cTECs isolated from K5D1 and K5D1-b5tKOmice. Plotted are log2 fold changes (K5D1-b5tKO cTECs/
K5D1 cTECs) of 20S proteasome components (left) and regulatory particle proteasome components (right) in two independent measurements.
(F) Immunoblot analysis of b5t, a6, a7, b3, Rpn1, andRpn13 proteins in cTECs andmTECs isolated fromK5D1mice andK5D1-b5tKOmice. b-actin was examined
as loading control.
(legend continued on next page)
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fold-change comparison of small amounts of proteins among
multiple samples (Berg et al., 2019). We noticed that 10 out of
11 b5t-derived peptide signals were completely absent prior
to the imputation in the label-free MS analysis of b5t-knockout
cTEC samples (Table S6), reconfirming the absolute absence of
actual b5t protein in b5t-deficient cTECs and suggesting that
the only positively detected peptide signal actually represented
a coincidentally detected false-positive signal unrelated to b5t.
In agreement with the MS measurements, immunoblot anal-
ysis demonstrated the loss in b5t subunit and the reduction in
non-catalytic proteasome components (a6, a7, b3, Rpn1, and
Rpn13) in cTECs from b5t-deficient mice (Figure 6F). Additional
immunoblot analysis of the catalytic proteasome components
reconfirmed the reduction in b1, b1i, and b2i; no apparent alter-
ation in b2; and the increase in b5 and b5i in b5t-deficient cTECs
(Figure 6G). Flow cytometric analysis further showed the com-
plete absence of b5t and the approximately 40% reduction of
a6 in cTECs from b5t-deficient mice in B6 background
(Figure 6H).
To further verify the alteration in the amounts of b5 and b5i
in cTECs from b5t-deficient mice, we synthesized b5, b5i, and
b5t proteins in bacteria and determined their sensitivities for
the absolute quantification of these proteins in immunoblot
analysis (Figure 6I). Measurements of the absolute amounts
of b5, b5i, and b5t proteins in equivalent amounts of TEC ly-
sates isolated from K5D1 mice revealed that unlike b5t+/+
cTECs, which predominantly expressed the b5t subunit, the
loss of b5t in b5t/ cTECs was accompanied by the abun-
dant expression of both b5 and b5i proteins (Figure 6J). In
addition to the 2-fold increase in the absolute amount of b5i
in b5t-deficient cTECs, the amount of b5 protein increased
markedly, at approximately 5-fold in b5t/ cTECs (Figure 6J).
The predominant detection of b5i rather than b5 in b5t-defi-
cient cTECs in a previous study (Nitta et al., 2010; also shown
in Figure 6G) was likely due to the lower sensitivity of b5 than
b5i by the antibody-mediated detection in the immunoblot
analysis (Figure 6I).
These results indicate that the quantitative proteomic profiles
of cTECs are highly similar between b5t/ and b5t+/+ mice.
However, the majority of proteasome components, including
the 20S core particle components and the 19S regulatory parti-
cle components, are modestly but specifically reduced in the
amount in cTECs as a consequence of a genetic loss of b5t.
On the contrary, b5i and b5 are elevated in amount to potentially
compensate the loss of b5t to maintain proteasome complexes
in b5t-deficient cTECs.(G) Immunoblot analysis of b5t, b5i, b5, b2i, b1i, b2, and b1 proteins in cTECs and
as loading control. Numbers show relative amounts of the signals normalized wi
(H) Histograms show the flow cytometric detection of b5t (top) and a6 (middle) alon
cTECs and mTECs from B6 mice (black line) and B6-b5tKO mice (red line). Num
right show the relative fluorescence intensity indexes (RFI; means and SEMs, n
(comparison between B6 and KO groups).
(I) Coomassie Brilliant Blue stained SDS-PAGE gels showing the production and p
of purified proteins were determined by a fluorometer and normalized to protein p
proteins (middle). Standard curves between the amounts of purified b5t-His, b
immunoblot signals on the y axis (bottom).
(J) Immunoblot analysis of b5t, b5i, and b5 proteins in indicated amounts (mg) of the
The amounts of indicated proteins (n = 3) were deduced according to the standaNo Constitutive Stress Response in cTECs in
b5t-Deficient Mice
Our results indicate that b5t-deficient cTECs have modestly
reduced amounts of most proteasome components. It was
demonstrated that a deficiency in proteasomes would ignite a
stress response in cells (Bush et al., 1997; Mathew et al.,
1998). We finally examined whether the modest reduction in
the amounts of many proteasome components detected in
b5t-deficient cTECs would impair proteasome activity and sub-
sequently trigger stress responses in cTECs. We found that the
proteasome activity detected by a cell-permeable triple-leucine
substrate-based fluorescent probe (Figure S7A) was not signifi-
cantly altered in b5t-deficient cTECs, indicating that control and
b5t-deficient cTECs were comparable in the chymotrypsin-like
proteolytic activity of the proteasomes (Figure 7A). The absence
of alteration in proteasome activity despite the reduction in the
amount might be due in part to the compensatory incorporation
of b5i into the proteasomes in b5t-deficient cTECs (Figure 6),
which could lead to the expression of b5i-containing immuno-
proteasomes having higher chymotrypsin-like activity than b5t-
containing thymoproteasomes (Murata et al., 2007; Sasaki
et al., 2015).
In agreement with the lack of reduction in proteasome activ-
ity, we detected no accumulation of ubiquitinated proteins in
b5t-deficient cTECs (Figures 7B and S7B), suggesting that
ubiquitinated proteins were degraded in b5t-deficient cTECs.
Accordingly, we detected no elevation of Sqstm1 mRNAs en-
coding the stress-responsive signaling adaptor protein p62
(Sánchez-Martı́n et al., 2019) in b5t-deficient cTECs isolated
from B6 background mice (Figure 7C). We also detected no
elevation of Nrf1 mRNAs in b5t-deficient cTECs (Figure 7D), a
gene encoding a transcription factor that plays an essential
role in the restoration of proteasome subunit genes during pro-
teasome impairment (Koizumi et al., 2018). In addition, ontology
analysis of proteomic profiles confirmed no manifestation of
endoplasmic reticulum stress response in b5t-deficient cTECs
(Figure 7E).
It is well appreciated that autophagy is constitutively active in
cTECs evenwithout nutritional deprivation and contributes to the
optimization of self-antigen processing for inducing T-cell selec-
tion (Nedjic et al., 2008). It was therefore interesting to examine
whether the loss of b5t would trigger signals to augment the
constitutive autophagy in cTECs. However, we detected the
comparable formation of LC3-containing autophagosomes in
cTECs between B6-b5t-deficient mice and control B6 mice (Fig-
ure 7F). Proteins associatedwith the ontology of autophagyweremTECs isolated from K5D1mice and K5D1-b5tKOmice. b-actin was examined
th those of actin.
g with the background signals detected by isotype control reagents (bottom) in
bers in histograms show the mean fluorescence intensity (MFI). Plots on the
= 4) of b5t (top) and a6 (bottom) expression. ***p < 0.001; n.s. not significant
urification of b5t-His, b5i-His, and b5-His proteins (top). The absolute amounts
urity. Immunoblot analysis of indicated amounts of b5t-His, b5i-His, and b5-His
5i-His, and b5-His proteins on the x axis and the integrated density of the
lysates of cTECs andmTECs isolated fromK5D1mice and K5D1-b5tKOmice.
rd curves shown in (I).
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Figure 7. No Constitutive Stress Response in cTECs in b5t-Deficient Mice
(A) Proteasome activity in b5t-deficient and control cTECs. Histograms show the detection of proteasome activity by cell-permeable triple-leucine substrate-
based fluorescent probe in cTECs andmTECs of B6mice (blue line) and B6-b5tKOmice (red line). Shaded area and black line represent background fluorescence
profiles without the addition of proteasome probe in B6 TECs and B6-b5tKO TECs, respectively. Plots on the right show relative fluorescence intensity index
(means and SEMs, n = 10–11). B6-ctrl indicates B6 and B6-b5tHet mice. n.s., not significant.
(B) Immunoblot analysis of ubiquitin in cTECs and mTECs isolated from K5D1 and K5D1-b5tKO mice. NIH 3T3 cells with or without proteasome inhibitor MG132
treatment were also examined.
(C and D) qPCR analysis of mRNA expression levels (means and SEMs, n = 10) of p62/Sqstm1 (C) and Nrf1 (D) relative to Gapdh in cTECs and mTECs isolated
from B6 and B6-b5tKO mice. n.s., not significant.
(E) Volcano plot analysis of TMT-based quantitative proteomes for K5D1-b5tKO cTECs and K5D1 cTECs, highlighting proteins with the ontology of ER stress
response (yellow symbols). Detected proteins are plotted as log2 fold changes (K5D1-b5tKO cTECs/K5D1 cTECs) versuslog10Q values. Black horizontal line in
the plot shows the Q value of 0.05.
(F) Immunofluorescence analysis of LC3 (red) and b5t-venus (green) in the thymic sections of B6-b5tHet (b5tVenus/+) and B6-b5tKO (b5tVenus/Venus) mice.
Representative data from two independent experiments are shown. Scale bars, 5 mm.
(G) Volcano plot analysis of TMT-based quantitative proteomes for K5D1-b5tKO cTECs and K5D1 cTECs, highlighting proteins with the ontology of autophagy
(yellow symbols). Detected proteins are plotted as log2 fold changes (K5D1-b5tKO cTECs/K5D1 cTECs) versuslog10 Q values. Black horizontal line in the plot
shows the Q value of 0.05.neither significantly nor coordinately altered in b5t-deficient
cTECs (Figure 7G).
In agreement with previous results showing the comparable
expression of surface MHC-I molecules in cTECs from b5t-defi-
cient mice of B6 background (Nitta et al., 2010) and the compa-
rable decay in surfaceMHC-I molecules in embryonic fibroblasts
that expressed b5t or b5i (Sasaki et al., 2015), we found that2912 Cell Reports 29, 2901–2916, November 26, 2019MHC-I expression and its decay in the presence of brefeldin A,
representing the stability ofMHC-I expression, were comparable
between K5D1 cTECs and B6 cTECs in the absence or presence
of b5t (Figure S7C).
These results indicate that despite the modest reduction in the
amounts of many proteasome components, b5t-deficient cTECs
are neither reduced in proteasomal chymotrypsin-like activity
nor accumulated with ubiquitinated proteins. Consequently, the
genetic loss of b5t neither triggers stress signals nor alters auto-
phagy in cTECs.
DISCUSSION
The present results demonstrate that the enlarged thymuses in
K5D1 mice are functionally potent in the production and selec-
tion of immunocompetent and self-tolerant T cells and so pro-
vide a useful source for the preparation of thymic cells, including
TEC subpopulations for biochemical analysis including proteo-
mic analysis, which requires a relatively large number of cells.
In contrast to normal mice, fromwhich fewer than 53 103 cTECs
and approximately 104 mTECs can be isolated per mouse (Gray
et al., 2006; Sakata et al., 2018), K5D1 mice readily enable the
isolation of more than 105 cTECs and more than 105 mTECs
from one mouse, which would enable practical sample prepara-
tion for mass-spectrometry-based quantitative proteomic anal-
ysis of cTECs and mTECs. The results described in this study
reveal previously unknown quantitative profiles of unbiased pro-
teomes in freshly isolated cTECs and mTECs. In combination
with transcriptomic analysis, our trans-omics analysis identifies
signature molecules that functionally and developmentally char-
acterize a sharp contrast between cTECs and mTECs.
The thymuses in K5D1 mice maintain the corticomedullary
structure and the T-cell-producing capability (Robles et al.,
1996; Klug et al., 2000; Bolner, 2015). Our results show that
the flow cytometric profiles of cTECs and mTECs, as well as
the CD4/CD8 and TCRb/TCRd profiles of thymocytes, are similar
between K5D1 thymuses and B6 thymuses. Accordingly, similar
to B6 thymuses, the cortical regions in the enlarged K5D1 thy-
muses are enriched with b5t+ cTECs and CD4/CD8 double-pos-
itive thymocytes, and the K5D1 thymic medullas contain Aire+
mTECs and CD4/CD8 single-positive thymocytes. Our results
further show that b5t+ cTECs in K5D1 mice are functionally
potent to optimize the CD8+ T-cell production, and Aire+ mTECs
in K5D1mice are essential for the establishment of self-tolerance
in T cells. Indeed, peripheral T cells generated in K5D1 mice are
functionally competent and self-tolerant. Thus, the hyperplastic
thymic microenvironments, including cTECs and mTECs, in
K5D1 mice are functionally capable of producing and selecting
immunocompetent and self-tolerant T cells. Moreover, in com-
parison with previous data (Sakata et al., 2018), our results
show that cTECs and mTECs can be isolated with an equivalent
efficiency between K5D1 and B6 thymuses. Thus, the thymuses
in K5D1 mice are a useful source of cTECs and mTECs for
biochemical analysis, including proteomic analysis that requires
relatively large-scale cell preparation.
Consequently, our trans-omics data (i.e., the combination of
transcriptomic and proteomic data) from cTECs and mTECs
offer a useful resource for further explorations of the biology of
TECs and their subpopulations. The list of the molecules whose
expression levels are significantly different between cTECs and
mTECs coordinately in both transcriptomic and proteomic ana-
lyses can be particularly useful. For example, it was previously
shown that the unique protein degradation machinery by
cathepsin L, TSSP, and b5t in cTECs is important for inducing
positive selection of functionally competent T cells (Murataet al., 2007; Nakagawa et al., 1998; Gommeaux et al., 2009;
Kondo et al., 2019). Our trans-omics analysis identifies that in
addition to cathepsin L, TSSP, and b5t, cathepsin D and calpain
1 are more abundant in cTECs than in mTECs. On the contrary,
cathepsin C, cathepsin H, and cathepsin Z are expressed more
abundantly in mTECs than cTECs, in addition to the previously
described cathepsin S. These proteases, which are distinctively
expressed in either cTECs or mTECs, may additionally play an
important role in self-antigen processing for the TCR repertoire
formation in T cells.
It is important to point out that cTECs isolated from either
K5D1 or B6 mice contain multicellular TNC complexes that
enclose CD4+CD8+ thymocytes. In comparison with cTECs,
mTECs can be far more easily separated from thymocytes, so
that both transcriptomic and proteomic profiles of mTECs are
essentially free from signals derived from co-purified thymo-
cytes. On the contrary, we have estimated that 20% to 27% of
RNAs and 3% to 5% of proteins extracted from isolated cTECs
originate from TNC-enclosed CD4+CD8+ thymocytes. Conse-
quently, the transcriptomic profiles of cTECs are considerably
affected by the co-purified CD4+CD8+ thymocytes, in agreement
with the transcriptomic data of cTECs reported by other groups
(Sansom et al., 2014; Immunological Genome Project, http://
www.immgen.org). In contrast, the proteomic profiles of cTECs
are only marginally affected by the proteins extracted from
TNC-enclosed CD4+CD8+ thymocytes, so that our proteomic
and trans-omics profiles of cTECs are largely free from signals
derived from CD4+CD8+ thymocytes.
Our unbiased and quantitative proteomic profiles reveal a high
similarity between cTECs isolated from b5t-deficient mice and
those from control mice. Strikingly, however, our data also reveal
that the majority of proteasome components, including the 20S
core particle components and the 19S regulatory particle com-
ponents, are modestly but specifically reduced in b5t-deficient
cTECs. On the contrary, b5i and b5 are elevated in amount,
potentially to compensate the loss of b5t and maintain protea-
some complexes in b5t-deficient cTECs, as demonstrated previ-
ously (Murata et al., 2007; Nitta et al., 2010). Our RNA
sequencing data show that the majority of proteasome compo-
nents were not significantly altered in mRNA amount in b5t-defi-
cient cTECs. The molecular mechanism for the coordinated
reduction in the majority of proteasome components in b5t-defi-
cient cTECs is unknown. It is known, however, that the b5 sub-
unit acts as an intramolecular chaperone to support proteasome
assembly (Chen andHochstrasser, 1996; Hirano et al., 2008) and
that b5i is incorporated preferentially over b5 into the protea-
some intermediates containing b1i and b2i subunits (Griffin
et al., 1998; Tanaka, 2009). It is possible that b5t is more efficient
than b5i or b5 in assembling with other components to form thy-
moproteasomes, so that the loss of b5t gene expression may
cause an inefficient proteasome assembly and thereby reduce
the number of proteasomes in b5t-deficient cTECs.
Interestingly, our data further show that proteasome activity
detected by a cell-permeable triple-leucine substrate-based
fluorescent probe is not significantly altered in b5t-deficient
cTECs, indicating that control and b5t-knockout cTECs are com-
parable in the chymotrypsin-like proteolytic activity of the pro-
teasomes. We think that the proteasomes in b5t-knockoutCell Reports 29, 2901–2916, November 26, 2019 2913
cTECs are altered in substrate preference and produce altered
MHC-I-associated peptidome, as previously suggested by the
experiments using embryonic fibroblasts (Sasaki et al., 2015).
We speculate that the absence of alteration in triple-leucine sub-
strate-based chymotrypsin-like activity in b5t-deficient cTECs
may be due in part to the compensatory incorporation of b5i
into proteasome complexes in b5t-deficient cTECs, which re-
sults in the expression of b5i-containing proteasomes having
higher chymotrypsin-like activity than the b5t-containing protea-
somes (Murata et al., 2007; Sasaki et al., 2015). Smaller amounts
of proteasomes with higher chymotrypsin-like activity may result
in no significant alteration of chymotrypsin-like activity in b5t-
deficient cTECs. We are amenable to the previous suggestion
that proteasomes in b5t-deficient cTECs are altered in substrate
preference and produce altered MHC-I-associated peptidome.
Indeed, a recent study showed that human thymoproteasomes
and immunoproteasomes differ in cleavage preference quantita-
tively and qualitatively (Kuckelkorn et al., 2019).
We further show that despite the reduction in many protea-
some components, b5t-deficient cTECs do not constitutively
ignite stress responses. It was previously demonstrated that
b5t-deficient cTECs are unable to optimize the production of
functionally potent CD8+ T cells (Murata et al., 2018; Nitta
et al., 2010; Takada et al., 2015). The present results showing
the specific alteration in proteasome components in b5t-defi-
cient cTECs without noticeable alteration in other proteins sup-
port the possibility that b5t in cTECs uniquely affects protea-
some-mediated processing of self-antigen peptides, which are
associated with MHC class I complexes to induce the positive
selection of CD8+ T cells (Murata et al., 2007; Nitta et al., 2010;
Sasaki et al., 2015; Tomaru et al., 2019), rather than pervasively
affecting other biological processes in cTECs for the regulation
of CD8+ T-cell production. It is important in the future to charac-
terize MHC class-I-associated peptides displayed by cTECs in
the presence or absence of b5t.
Our quantitative proteomic profiles also show that the majority
of proteasome components, including the 20S core particle
components and the 19S regulatory particle components, are
significantly more abundant in cTECs than in mTECs. Indeed,
higher proteasome activity is detected in cTECs than in mTECs.
However, neither the accumulation of ubiquitinated proteins nor
the elevation of p62 and Nrf1 mRNAs is detectable even in
mTECs, suggesting that the proteasome activity detected in
mTECs is sufficient for mTECs to maintain cellular homeostasis.
As cTECs are larger in size (Nakagawa et al., 2012) and more
abundant in proteins (this study) than mTECs, cTECs may
require higher proteasome activity than mTECs to maintain
cellular survival and functions.
Finally, our results show that the hyperplastic thymuses in
K5D1 mice are functionally capable of producing and selecting
immunocompetent and self-tolerant T cells. Our results also
show that in comparison with the thymuses in normal B6 mice,
the thymuses in K5D1 mice are massively enlarged with an
approximately 80- to 100-fold larger number of TECs. Accord-
ingly, the cellularity of thymocytes in K5D1 mice increases to
approximately 30- to 50-fold the cellularity in B6mice.We further
note that T cells in the spleens of K5D1 mice are elevated in the
cellularity with a 2- to 3-fold increase. It is clear that the numbers2914 Cell Reports 29, 2901–2916, November 26, 2019of both thymocytes and peripheral T cells are elevated propor-
tionally with the increase in TEC cellularity, in agreement with a
previous study of the engraftment of a graded number of thymic
lobes (Berzins et al., 1999). However, the disparity between
massive thymus enlargement and modest T-cell increase in the
periphery suggests the presence of a homeostatic mechanism
that limits peripheral T-cell numbers. These implications may
be important to work seeking to improve the recovery of
T cells in various clinical settings through the reconstitution of
TECs (van den Brink et al., 2004; Chaudhry et al., 2016). It is
possible that the export of mature thymocytes to the circulation
is limited in the enlarged thymus in K5D1 mice, as suggested
previously (Bolner, 2015).
In conclusion, the present study using K5D1mice allowsmass-
spectrometry-based quantitative proteomic analysis of cTECs
and mTECs. Our results reveal a highly specific impact of the thy-
moproteasome on proteasome subunit composition in cTECs.
The reproducible reduction of proteasome components not only
in b5t-deficient K5D1 cTECs, but also in b5t-deficient B6 cTECs,
as well as the high similarity in transcriptomic profiles between
K5D1 TECs and B6 TECs, verifies the usefulness of our proteomic
profiles obtained from K5D1 TECs in studies of the biology of
TECs. Although it is important in the future to reveal proteomic
profiles of TECs in normal mice, the present results offer an inte-
grated trans-omics platform for further explorations of the biology
of TECs and thymic microenvironments.STAR+METHODS
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E., Machado, A., Chuprin, A., Tóth, B., et al. (2018). Single-cell mapping of thethymic stroma identifies IL-25-producing tuft epithelial cells. Nature 559,
622–626.
Bush, K.T., Goldberg, A.L., and Nigam, S.K. (1997). Proteasome inhibition
leads to a heat-shock response, induction of endoplasmic reticulum chaper-
ones, and thermotolerance. J. Biol. Chem. 272, 9086–9092.
Chaudhry, M.S., Velardi, E., Dudakov, J.A., and van den Brink, M.R. (2016).
Thymus: the next (re)generation. Immunol. Rev. 271, 56–71.
Chen, P., and Hochstrasser, M. (1996). Autocatalytic subunit processing cou-
ples active site formation in the 20S proteasome to completion of assembly.
Cell 86, 961–972.
Derbinski, J., and Kyewski, B. (2010). How thymic antigen presenting cells
sample the body’s self-antigens. Curr. Opin. Immunol. 22, 592–600.
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highly cross-adsorbed secondary antibody
Invitrogen Cat# A-11034, RRID:AB_ 2576217
Sheep anti-mouse IgG ECL antibody, HRP conjugated GE Healthcare Cat# NA9310-1ml, RRID:AB_772193
Donkey anti-rabbit IgG ECL antibody, HRP conjugated GE Healthcare Cat# NA9340-1ml, RRID:AB_772191
Goat anti-rat IgG, whole Ab ECL antibody, HRP
conjugated
GE Healthcare Cat# NA935, RRID:AB_772207
Chemicals, Peptides, and Recombinant Proteins
Liberase TM Research Grade Roche Cat# 5401127001
DNase I recombinant, RNase-free Roche Cat# 04716728001




MG132 (Proteasome inhibitor) AdooQ Bioscience Cat# A11043
MG-132, R 95% by HPLC Millipore Cat# 474787
Brefeldin A Sigma Aldrich Cat# B5936
Critical Commercial Assays
Cell Trace Violet Cell Proliferation Kit Thermo Fisher Scientific Cat# C34557
His Bind Purification Kit Novagen Cat# 70239
RNeasy Plus Micro Kit QIAGEN Cat# 74034
SMART-Seq v4 Ultra Low Input RNA Kit
for Sequencing
Clontech Cat# 634888
Nextera XT DNA Library Preparation Kit Illumina Cat# FC-131-1024
RapiGest SF Surfactant Waters Cat# 186001861
Trypsin/Lys-C Mix, Mass Spec Grade Promega Cat# V5072
Pierce Quantitative Colorimetric Peptide Assay Thermo Fisher Scientific Cat# 23275
TMT10plex Isobaric Label Reagent Set Thermo Fisher Scientific Cat# 90309
Pierce High pH Reversed-Phase Peptide
Fractionation Kit
Thermo Fisher Scientific Cat# 84868
Deposited Data
RNA sequencing data The DNA Data Bank of Japan DRA008167, DRA008878
MS proteomics data jPOST partner repository PXD013132, PXD013133
Experimental Models: Cell Lines
NIH 3T3 ATCC Cat# CRL-1658, RRID:CVCL_0594
Experimental Models: Organisms/Strains
Mouse: C57BL/6N SLC Japan N/A
Mouse: C57BL/6J The Jackson Laboratory RRID:IMSR_JAX:000664
Mouse: BALB/cJ The Jackson Laboratory RRID:IMSR_JAX:000651
Mouse: DBA/2J The Jackson Laboratory RRID:IMSR_JAX:000671
Mouse: Keratin 5 promoter-driven Cyclin D1 Tg Robles et al., 1996 N/A
Mouse: b5t/ (b5t Venus/Venus) Murata et al., 2007 N/A
Mouse: b5t/ (b5t Cre/Cre) Ohigashi et al., 2013 N/A
Mouse: b5i/ Fehling et al., 1994 N/A
(Continued on next page)
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Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Recombinant DNA
pET28a-b5 Shigeo Murata, University of Tokyo N/A
pET28a-b5i Shigeo Murata, University of Tokyo N/A
pET28a-b5t Shigeo Murata, University of Tokyo N/A
Software and Algorithms
GraphPad Prism GraphPad Software RRID:SCR_002798
FlowJo FlowJo RRID:SCR_008520
ImageJ NIH RRID:SCR_003070
CLC Genomics Workbench QIAGEN RRID:SCR_011853
DAVID Leidos Biomedical Research, Inc RRID:SCR_001881
Proteome Discoverer Thermo Fisher Scientific RRID:SCR_014477
Adobe Photoshop Adobe RRID:SCR_014199LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for reagents may be directed to and will be fulfilled by the Lead Contact, Yousuke Takahama
(yousuke.takahama@nih.gov). This study did not generate new unique reagents.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice
C57BL/6 (B6) mice were obtained from SLC Japan and The Jackson Laboratory. BALB/c and DBA/2mice as well as B6-b5i-deficient
mice (Fehling et al., 1994) were obtained from The Jackson Laboratory. Keratin 5 promoter-driven cyclin D1-transgenic (K5D1) mice
(Robles et al., 1996) and b5t-deficient mice (Murata et al., 2007; Ohigashi et al., 2013) were described previously and backcrossed to
B6 background. For most experiments including proteomic analysis, male and female mice were analyzed at 12 to 20 weeks old in an
age-matched and sex-matchedmanner. Mice were housed on a 12-hour light-dark cycle in climate-controlled, pathogen-free barrier
facilities. All mouse experiments were performed with consent from the Animal Experimentation Committee of the University of
Tokushima (T28-58) and from the Animal Care and Use Committee of the National Cancer Institute (ASP 18-431 and EIB-076-2).
Cells
NIH 3T3 cells (male) were grown in Dulbecco’s Modified EagleMedium (Nacalai Tesque), supplemented with 10% fetal bovine serum
(Invitrogen), penicillin (100 I.U./mL) and streptomycin (100 mg/mL) (GIBCO) at 37C and 5% CO2. Where needed, NIH 3T3 cells were
cultured in the presence of MG132 (100 mM) overnight.
METHOD DETAILS
Thymus section analysis
Thymus tissues were fixed with 4% (g/vol) paraformaldehyde (PFA) and embedded in OCT optimum cutting temperature compound
(Sakura Finetek). Frozen thymuses were sliced into 10-mm-thick sections and stained with antibodies specific for b5t (Murata et al.,
2007; MBL), Aire (Invitrogen, clone 5H12), and LC3B (Cell Signaling Technology, clone D11), followed by AlexaFluor-conjugated
anti-IgG antibodies (Invitrogen). Sections were also stained for the reactivity with UEA1 (Vector Laboratories). For the staining
with antibodies specific for CD4 (Invitrogen, clone RM4-5) and CD8a (Invitrogen, clone 53-6.7) in addition to the staining for the reac-
tivity with UEA1, thymus tissues were embedded, sliced, and fixed with acetone. Images were visualized and analyzed with a TCS
SP8 (Leica) or an ECLIPSE Ti2 (Nikon) confocal laser scanning microscope.
For the measurement of the area of thymic regions, frozen thymuses were sliced into 10-mm-thick sections, fixed with neutral
buffered formalin, stained with hematoxylin and eosin (Muto Pure Chemicals), and imaged under an Eclipse E1000 microscope
(Nikon). The areas of the cortical andmedullary regions in the thymic sections were measured by using Photoshop software (Adobe).
Flow cytometric analysis
For the analysis of thymocytes and spleen cells, cells were multicolor stained for CD4 (BioLegend, clone RM4-5), CD8a (Invitrogen,
clone 5H10), CD25 (BD PharMingen, clone PC61), CD69 (BD PharMingen, clone H1.2F3), H-2Kb MHC class I (Invitrogen, clone AF6-
88.5.5.3), TCRb (BioLegend, clone H57), and TCRd (BD PharMingen, clone GL3). Where indicated, thymocytes were stained forCell Reports 29, 2901–2916.e1–e6, November 26, 2019 e3
CCR7 (Invitrogen, clone 4B12) at 37C for 30 min before the staining with other antibodies. Multicolor flow cytometry was performed
on FACSVerse, LSR II, LSRFortessa, and LSRFortessa X-20 (BD Biosciences). Flow cytometric data was analyzed using FlowJo.
Single-cell analysis and isolation of TECs
For single-cell analysis and isolation of TECs, minced thymuses were digested with 0.5 unit/mL Liberase TM (Roche) in the presence
of 0.02%DNase I (Roche). Single-cell suspensionswere stained for the expression of EpCAM (CD326, BioLegend, cloneG8.8), CD45
(BioLegend, clone 30-F11), Ly51 (CD249, BioLegend, clone 6C3), and for the reactivity with UEA-1 (Vector Laboratories). For the
intracellular staining of a6, b5t, and b-catenin in TECs, surface-stained cells were fixed with 2% (g/vol) paraformaldehyde, permea-
bilized with 0.05% saponin, and stained with anti-a6 antibody (Murata et al., 2007), anti-b5t antibody (Murata et al., 2007), and anti-
b-catenin antibody (BD Transduction Laboratories, clone 14), followed by AlexaFluor-conjugated anti-IgG antibody (Invitrogen). For
the measurement of proteasome activity in TECs, surface-stained cells were incubated with 1 mM cell-permeable fluorescent pro-
teasome activity probe (Me4BodipyFL-Ahx3Leu3VS, Boston Biochem) at 37
C for 60 min. Where indicated, cells were incubated
at 37C for 30 min in the presence of 1 mM or 10 mM MG132 prior to the incubation with the proteasome activity probe.
For the measurement of cell-surface expression and its decay of MHC class I molecule H-2Kb (detected by clone AF6-88.5, BD
Biosciences) on TECs, liberase-digested thymic cells were cultured in the presence of 5 mg/ml brefeldin A (Sigma Aldrich) for 2
and 4 hours before multicolor flow cytometric analysis of cell-surface molecules.
For the isolation of TECs, CD45- cells were enriched with magnetic-bead-conjugated anti-CD45 antibody (Miltenyi Biotec) before
multicolor staining for flow cytometric cell sorting. For the isolation of TECs from enlarged K5D1 thymuses, cells were enriched by
Percoll density gradient centrifugation before the magnetic enrichment of CD45- cells. Multicolor flow cytometry and cell sorting of
TECs were performed on FACSVerse and FACSAria II (BD Biosciences).
Immunofluorescence analysis of isolated TECs
cTECs and mTECs were fixed with 4% (g/vol) PFA, permeabilized with 0.05% saponin, and stained with anti-CD45 antibody
(BioLegend, clone 30-F11). Cells were collected on a slide glass by centrifugation at 1,800 rpm for 10 min by using Cytospin 4
(Thermo Fisher). Fluorescence images were analyzed under a TCS SP8 confocal laser scanning microscope (Leica).
Allogeneic T cell response
Spleen cells from 1315-week-old B6 and K5D1 mice were labeled with 5 mM Cell Trace Violet (Thermo Fisher) at 37C for 20 min.
Spleen cells from 6- to 7-week-old mice were irradiated at 20 Gy for stimulator cells. Labeled cells (2 3 106) were cultured with
stimulator cells (8 3 106) at 37C for 6 days. Cell Trace Violet fluorescence in TCRbhigh T cells was measured by flow cytometry.
Fluorometric measurement of RNA and proteins
Total cellular RNA was extracted by using a RNeasy Plus Micro Kit (QIAGEN). For protein extraction, cells were lysed in 150 mL of 6 M
guanidine-HCl containing 100 mM Tris-HCl, pH 8.0 and 2mMDTT. The amounts of RNAs and proteins were measured using a Qubit
RNA HS Assay Kit and a Qubit Protein Assay Kit, respectively, with a Qubit Fluorometer (Thermo Fisher).
RNA sequencing analysis
cDNAs were prepared from 3,000 isolated cells by using SMART-Seq v4 Ultra Low Input RNA Kit, according to the manufacturer’s
protocol (Clontech). Sequencing libraries were generated by using a Nextera XT DNA Library Prep Kit, according to the manufac-
turer’s protocol (Illumina). The concentration of libraries wasmeasured by an ABI PRISM 7500 Real-time PCR system in combination
with a Power SYBR Green PCR Master Mix (Thermo Fisher). Single-end sequencing of cDNA libraries with a read length of 50 was
performed with HiSeq 1500 platform (Illumina). Data were analyzed by using CLC Genomics Workbench 11 (QIAGEN) with default
parameters.
TMT proteomic analysis
Approximately 1 to 33 105 cells (K5D1 cTECs in quadruplicate, K5D1mTECs in triplicate, and K5D1-b5tKO cTECs in triplicate) were
lysed in 150 mL of 6 M guanidine-HCl containing 100mM Tris-HCl, pH 8.0, and 2 mMDTT. The lysates were dissolved by heating and
sonication, followed by centrifugation at 20,000 x g for 15 min at 4C. The supernatants were reduced in 5 mM DTT at room temper-
ature for 30 min and alkylated in 27.5 mM iodoacetamide at room temperature for 30 min in the dark. Proteins were purified by meth-
anol/chloroform precipitation and solubilized with 25 mL of 0.1% RapiGest SF (Waters) in 50 mM triethylammonium bicarbonate
buffer. After repeated sonication and vortexing, the proteins were digested with 0.5 mg of trypsin/Lys-C mix (Promega) for 16 hr at
37C. Peptide concentration was determined using Pierce Quantitative Colorimetric Peptide Assay (Thermo Fisher). Approximately
10 mg of peptides for each sample was labeled with 0.2 mg of TMT10-plex reagents (Thermo Fisher) for 1 hr at room temperature.
After the reaction was quenched with hydroxylamine, all the TMT-labeled samples were pooled, acidified with trifluoroacetic acid
(TFA) and fractionated using a Pierce High pH Reversed-phase Peptide Fractionation Kit (Thermo Fisher). Ten fractions were
collected using 5%, 10%, 12.5%, 15%, 17.5%, 20%, 22.5%, 25%, 50%, and 80% acetonitrile (ACN). Each fraction was evaporated
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LC-MS/MS analysis of the resultant peptides (1 mg each) was performed on an EASY-nLC 1200 UHPLC connected to a Q Exactive
Plus mass spectrometer through a nanoelectrospray ion source (Thermo Fisher). The peptides were separated on a 75 mm inner
diameter 3 150 mm C18 reversed-phase column (Nikkyo Technos) with a linear gradient of 4%–20% ACN for 0–180 min and
20%–32% ACN for 180–220 min, followed by an increase to 80% ACN for 220–230 min. The mass spectrometer was operated in
the data-dependent acquisition mode with a top 15 MS/MSmethod. MS1 spectra were measured at a resolution of 70,000, an auto-
matic gain control (AGC) target of 33 106 and amass range of 375 to 1,400m/z. HCDMS/MS spectra were acquired at a resolution of
35,000, an AGC target of 13 105, an isolation window of 0.4m/z, a maximum injection time of 100 msec and a normalized collision
energy of 32. Dynamic exclusion was set to 30 s. Raw data were directly analyzed against Swiss-Prot database restricted to Mus
musculus using Proteome Discoverer version 2.2 (Thermo Fisher) with Mascot search engine version 2.5 (Matrix Science) for iden-
tification and TMT quantification. The search parameters were (a) trypsin as an enzyme with up to two missed cleavages, (b) precur-
sor mass tolerance of 10 ppm, (c) fragment mass tolerance of 0.02 Da, (d) TMT of lysine and peptide N terminus and carbamidome-
thylation of cysteine as fixed modifications, and (e) acetylation of protein N terminus and oxidation of methionine as variable
modifications. Peptides and proteins were filtered at the false-discovery rate (FDR) of 1% using the percolator node and the protein
FDR validator node, respectively.
Intrinsic to the TMT-MS technology, TMT target ions are frequently accompanied by a small amount of contaminating TMT ions
(Ow et al., 2009; Ting et al., 2011; also described in Thermo Fisher technical information). When the amount of reporter signals
from target ions is large, the contribution of the contaminating ions is negligible. However, when the amount of reporter signals
from target ions is small or even zero, the contaminating ions dominate the signals and thus create bias in the quantification
(Ow et al., 2009; Ting et al., 2011). In the case of TMT-MS measurement of b5t, the reason why a small amount of b5t was detected
in b5t-deficient cTECs isolated from b5t-deficient mice is the detection of contaminating ions. Indeed, the abundant detection of b5t
peptide signals in control cTEC samples created a precursor isolation window for all of the simultaneously analyzed samples,
including cTEC samples from b5t-deficient mice. The precursor isolation window for b5t caused the distorted detection of contam-
inating ions in b5t-deficient cTEC samples.
Label-free proteomic analysis
Proteins were prepared as above (TMT proteomic analysis) and digested with trypsin/Lys-C mix for 16 hr at 37C. The digests were
desalted using GL-Tip SDB (GL Sciences), and the eluates were evaporated in a SpeedVac concentrator and dissolved in 0.1% TFA.
LC-MS/MS analysis of the resultant peptides (400 ng each) was performed on an EASY-nLC 1200 UHPLC connected to a Q
Exactive Plus mass spectrometer. The peptides were separated with a linear gradient of 4%–28% ACN for 0–150 min followed
by an increase to 80% ACN during 150–170 min. The mass spectrometer was operated in the data-dependent acquisition mode
with the top 10 MS/MS method. MS1 spectra were measured at a resolution of 70,000, an AGC target of 13 106 and a mass range
of 350 to 1,500m/z. HCD MS/MS spectra were acquired at a resolution of 17,500, an AGC target of 5 3 104, an isolation window of
2.0m/z, a maximum injection time of 60 msec and a normalized collision energy of 27. Dynamic exclusion was set to 10 s. Raw data
were directly analyzed against Swiss-Prot database restricted toMus musculus using Proteome Discoverer version 2.2 with Mascot
search engine version 2.5 for identification and label-free precursor ion quantification.
The search parameters were (a) trypsin as an enzymewith up to twomissed cleavages, (b) precursor mass tolerance of 10 ppm, (c)
fragment mass tolerance of 0.02 Da, (d) carbamidomethylation of cysteine as a fixed modification, and (e) acetylation of protein N
terminus and oxidation ofmethionine as variablemodifications. Peptides and proteins were filtered at the FDR of 1%using the perco-
lator node and the protein FDR validator node, respectively. Normalization was performed such that the sum total of abundance
values for each sample over all peptides was the same.
Quantitative RT-PCR analysis
Total cellular RNAwas reverse-transcribed (RT) with PrimeScript Reverse Transcriptase (TaKaRa). Quantitative real-time polymerase
chain reaction (PCR) was performed using SYBR Premix Ex Taq (TaKaRa) and a StepOnePlus Real-Time PCR System or a
QuantStudio 6 Flex Real-Time PCR System (Applied Biosystems). The amplified products were confirmed to be single bands by
gel electrophoresis.
Purification of His-tag proteins
Full-length cDNAs encoding b5, b5i, and b5t were amplified from the tissues obtained from C57BL/6 mice and cloned into pET28a
vector (Novagen). All constructs were verified by sequencing. BL21 (DL3) competent E. coliwere transformed with the plasmids that
encoded the polyhistidine-tagged (His-Tag) b5, b5i, or b5t proteins were induced by 1 mM isopropyl b-d-1-thiogalactopyranoside
(IPTG) at 25C for overnight, and purified by His Bind Kit according to the manufacturer’s protocol (Novagen).
Immunoblotting
Total cell lysates (2.5, 5, or 10 mg) were separated by electrophoresis on a 12%polyacrylamide gel and transferred onto a PVDFmem-
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overnight at room temperature, followed by incubation with HRP-conjugated secondary antibodies. Protein bands on themembrane
were detected with a ChemiDoc Touch Imaging System (Bio-Rad) or a Light Capture II (Atto) after incubation of the membrane with
Clarity Western ECL Substrate (Bio-Rad).
Gene ontology term analysis
Gene ontology for transcriptomic and proteomic data was analyzed by using DAVID Bioinformatics Resources 6.8 (https://david.
ncifcrf.gov).
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis was carried out using GraphPad Prism 7 software, unless otherwise noted. Statistical significance was assessed
using the two-tailed unpaired Student’s t test with Welch’s correction for unequal variances. Q value was calculated using the mul-
tiple unpaired t test with the false discovery rate approach (Benjamini and Hochberg, 1995). Quantification of proteins detected by
immunoblot analyses was performed by using ImageJ v1.49 software. All values are expressed as means and SEMs, unless other-
wise specified. The n numbers are indicated in figure legends.
DATA AND CODE AVAILABILITY
RNA sequencing data have been deposited in The DNA Data Bank of Japan (DDBJ, https://www.ddbj.nig.ac.jp) with the accession
number DRA008167 andDRA008878.MSproteomics data have been deposited to ProteomeXchange Consortium via jPOST partner
repository (https://repository.jpostdb.org) with the dataset identifiers PXD013132 and PXD013133.e6 Cell Reports 29, 2901–2916.e1–e6, November 26, 2019
